CompletedPhase 3

Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)

Brazil60 participantsStarted 2008-02

Plain-language summary

Is the valproic acid efficacy to treat TSP/HAM

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HTLV-1; TSP/HAM fulfill criteria Exclusion Criteria: * Age \<18 years

Neurological sacles

Timeframe: 24 months

NCT IDNCT00681980

SponsorUniversity of Sao Paulo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-09